Evaluating the effectiveness of the DESyne X2 coronary stent in clinical practice

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses the effectiveness and safety of the DESyne X2 drug-eluting coronary stent in patients undergoing percutaneous coronary intervention (PCI) for coronary stenosis and occlusion. Participants aged 19 and older who consent to the intervention will be monitored in routine clinical settings. The study aims to gather real-world data on the performance of this stent in treating coronary disease. It will exclude patients with concurrent stent interventions or those with a life expectancy of less than one year.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 19 and more
* Intervention with DeSyne X2 drug-eluting coronary stent
* Agreed with written informed consent form

Exclusion Criteria:

* Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
* Life expectancy of 1year and under
* Cardiac shock

Where it's running

• Hallym Hospital
  Incheon, South Korea Recruiting
• Asan Medical Hospital
  Seoul, South Korea Recruiting
• Korea University Guro Hospital
  Seoul, South Korea Terminated
• The Catholic University of Korea Seoul St. Mary's Hospital
  Seoul, South Korea Withdrawn
• The Catholic University of Korea, Eunpyeong St. Mary's Hospital
  Seoul, South Korea Terminated
• St.carollo Hospital
  Suncheon, South Korea Terminated

Study contacts

• Study coordinator: Jung-hee Ham, RN
• Email: cvcrc5@amc.seoul.kr
• Phone: 82230104728

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PCI Registry at University Hospital Basel for Complex Coronary Procedures

  This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07814157

• Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients

  This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.

  Recruiting Fondazione Ricerca e Innovazione Cardiovascolare ETS · Milan, MI · NCT06535568

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• Mobile-based home cardiac rehab to see if it reduces non-calcified coronary plaque

  A mobile, at-home cardiac rehabilitation program is being tested to see if it can reduce non-calcified plaque in people with mild to moderate coronary artery narrowing.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT07660419

• QFR-guided virtual stenting to optimize PCI before the procedure

  We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07635407

• Poland registry of procedures to open completely blocked coronary arteries (chronic total occlusions)

  This project will see how well and how safely percutaneous coronary intervention (PCI) works for people in Poland who are having procedures to open chronic total coronary occlusions.

  Recruiting at 21 sites National Institute of Cardiology, Warsaw, Poland · Bialystok and 20 other locations · NCT07330622

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.